https://www.selleckchem.com/products/fx-909.html
for a bail-out operation in acute cholecystitis. Further study is needed to determine whether indocyanine green use is justified in this population. Patients with advanced differentiated thyroid cancer develop resistance to lenvatinib treatment from metabolic dysregulation. Heat shock protein 90 is a molecular chaperone that plays an important role in glycolysis and metabolic pathway regulation. We hypothesize that lenvatinib-resistant differentiated thyroid cancer cells will have an increased dependency on glycolysis and that a novel C-